Achieve Life Sciences (ACHV) Operating Expenses (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Operating Expenses came in at $10.5 million in Q1 2026, down 18.85% YoY from $12.9 million in Q1 2025, and down 28.97% on a QoQ basis from $14.7 million in Q4 2025.
Achieve Life Sciences (ACHV) Operating Expenses (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Operating Expenses data on file, last reported at $10.5 million in Q1 2026.
- Quarterly Operating Expenses fell 18.85% year-over-year to $10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.4 million (up 14.07% YoY) and the FY2025 annual result came in at $54.9 million, up 40.47% from the prior year.
- Operating Expenses eased to $10.5 million in Q1 2026, from $14.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $14.7 million in Q4 2025 to a low of $4.4 million in Q4 2023.
- A 5-year average of $10.1 million and a median of $10.5 million in 2026 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses plunged 59.62% — and 2024, when it soared 177.93%.
- Tracing ACHV's Operating Expenses over 5 years: stood at $10.9 million in 2022, then plunged by 59.62% to $4.4 million in 2023, then soared by 177.93% to $12.2 million in 2024, then climbed by 20.84% to $14.7 million in 2025, then dropped by 28.97% to $10.5 million in 2026.
- The last three Operating Expenses figures came in at $10.5 million (Q1 2026), $14.7 million (Q4 2025), and $14.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | 18.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.39 Mn |
| Mar 31, 2026 | 10.46 Mn |
| Dec 31, 2025 | 14.73 Mn |
| Sep 30, 2025 | 14.69 Mn |
| Jun 30, 2025 | 12.56 Mn |
| Mar 31, 2025 | 12.89 Mn |
| Dec 31, 2024 | 12.19 Mn |
| Sep 30, 2024 | 12.47 Mn |
| Jun 30, 2024 | 8.43 Mn |
| Mar 31, 2024 | 5.98 Mn |
| Dec 31, 2023 | 4.39 Mn |
| Sep 30, 2023 | 6.57 Mn |
| Jun 30, 2023 | 7.71 Mn |
| Mar 31, 2023 | 8.58 Mn |
| Dec 31, 2022 | 10.86 Mn |
| Sep 30, 2022 | 12.64 Mn |
| Jun 30, 2022 | 10.07 Mn |
| Mar 31, 2022 | 7.23 Mn |
| Dec 31, 2021 | 7.12 Mn |
| Sep 30, 2021 | 6.69 Mn |